Tylenol maker to pay $25 million for selling metal-contaminated drugs

March 10, 2015 8:37 PM

13 0

WASHINGTON (Reuters) - A Johnson & Johnson subsidiary pleaded guilty on Tuesday to selling liquid medicine contaminated with metal and agreed to pay $25 million to resolve the case, the U.S. Department of Justice said on Tuesday.

The subsidiary, McNeil Consumer Healthcare, pleaded guilty to one federal criminal charge in the case.

Read more

To category page